申请人:Ito Masaharu
公开号:US20090143438A1
公开(公告)日:2009-06-04
The object is to provide an excellent pharmaceutical having an anti-
Helicobacter pylori
activity. Disclosed is a novel pyridine derivative represented by the following general formula (I):
wherein R represents a linear or branched hydroxyalkyl group having 5 to 10 carbon atoms, or a pharmaceutically acceptable salt thereof, which has a potent antibacterial activity against
H. pyroli
(
Helicobacter pyroli
) Examples of the disease which can be prevented/treated by administration of a pharmaceutical agent comprising the compound include gastritis, gastric ulcer, duodenal ulcer, gastric MALT lymphoma, gastric hyperplastic polyp, development of gastric cancer after endoscopic resection of the early stage of gastric cancer and the like.
本发明旨在提供一种具有抗幽门螺杆菌活性的优秀药物。本发明公开了一种新型吡啶衍生物,其表示为以下通式(I):其中R代表具有5至10个碳原子的线性或支链羟基烷基,或其药学上可接受的盐,该化合物具有强效的抗H. pyroli(幽门螺杆菌)细菌活性。包括胃炎、胃溃疡、十二指肠溃疡、胃MALT淋巴瘤、胃部增生性息肉、内窥镜下切除早期胃癌后胃癌的发展等疾病可以通过给药含有该化合物的药物来预防/治疗。